Moody National Bank Trust Division Bei Gene, Ltd. Transaction History

Moody National Bank Trust Division

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$113.99 - $146.86 $13,906 - $17,916	-122 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$122.82 - $151.83 $12,404 - $15,334	101 Added 480.95%	122 $16,000
Q4 2018 Jan 07, 2019	BUY	$107.01 - $175.15 $2,247 - $3,678	21 New	21 $3,000

251

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.